Scribd Logo
Upload

Welcome to Scribd!

  • TEPZZ - Z6 - 58A - T: European Patent Application

    Uploaded by

    ferey
    11 views1 page
    This patent application relates to using vitamin K2 to treat macular degeneration. It claims that administering vitamin K2, or its precursors, can effectively prevent or treat macular degeneration, and may even stop its progression or improve vision. The vitamin K2 is preferably combined with magnesium, zinc, and/or vitamin D.

    Original Description:

    Original Title

    Export1

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This patent application relates to using vitamin K2 to treat macular degeneration. It claims that administering vitamin K2, or its precursors, can effectively prevent or treat macular degeneration, and may even stop its progression or improve vision. The vitamin K2 is preferably combined with magnesium, zinc, and/or vitamin D.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    11 views1 page

    TEPZZ - Z6 - 58A - T: European Patent Application

    Uploaded by

    ferey
    This patent application relates to using vitamin K2 to treat macular degeneration. It claims that administering vitamin K2, or its precursors, can effectively prevent or treat macular degeneration, and may even stop its progression or improve vision. The vitamin K2 is preferably combined with magnesium, zinc, and/or vitamin D.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    TEPZZ¥_Z6_58A_T

    (19)

    (11) EP 3 106 158 A1


    (12) EUROPEAN PATENT APPLICATION

    (43) Date of publication: (51) Int Cl.:


    21.12.2016 Bulletin 2016/51 A61K 31/122 (2006.01) A61P 27/02 (2006.01)

    (21) Application number: 16175089.8

    (22) Date of filing: 17.06.2016

    (84) Designated Contracting States: (71) Applicant: Wagenaar, Louis Johan


    AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 2314 GC Leiden (NL)
    GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
    PL PT RO RS SE SI SK SM TR (72) Inventor: WAGENAAR, Louis Johan
    Designated Extension States: 2314 GC LEIDEN (NL)
    BA ME
    Designated Validation States: (74) Representative: EP&C
    MA MD P.O. Box 3241
    2280 GE Rijswijk (NL)
    (30) Priority: 19.06.2015 NL 2015000

    (54) VITAMIN K2 AND MACULA DEGENERATION

    (57) The present invention relates to the effective ministration of vitamin K, or precursor thereof, irrespec-
    prevention or treatment of macula degeneration, prefer- tive of the form used, but preferably vitamin K2 or a pre-
    ably stopping the macula degeneration, or even improv- cursor thereof. With further preference, vitamin K(2) is
    ing the patient’s sight. This is achieved by means of ad- combined with magnesium, zinc, and/or vitamin D.
    EP 3 106 158 A1

    Printed by Jouve, 75001 PARIS (FR)

    You might also like